- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: fibrous dysplasia.
Displaying page 1 of 1.
| EudraCT Number: 2006-003549-18 | Sponsor Protocol Number: 004/001 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Cliniques Universitaires SAINT-LUC | |||||||||||||
| Full Title: REDUCTION OF BONE MORBIDITY USING AN ORAL BISPHOSPHONATE IN FIBROUS DYSPLASIA OF BONE (PROFIDYS Trial) | |||||||||||||
| Medical condition: Fibrous dysplasia •Study I: patients with fibrous dysplasia of bone, with bone pain intensity above 3 on a visual analogical scale from 0 to 10. •Study II: patients with fibrous dysplasia of bone... | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-024282-41 | Sponsor Protocol Number: 2010.648 | Start Date*: 2012-12-05 | |||||||||||
| Sponsor Name:Hospices Civils de Lyon | |||||||||||||
| Full Title: TRAITEMENT DE LA DYSPLASIE FIBREUSE DES OS CHEZ LES PATIENTS NON REPONDEURS AUX BISPHOSPHONATES PAR LE TOCILIZUMAB. L’ESSAI TOCIDYS | |||||||||||||
| Medical condition: dysplasie fibreuse des os | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-002611-29 | Sponsor Protocol Number: 82050 | Start Date*: 2023-06-12 |
| Sponsor Name:Leiden University Medical Center | ||
| Full Title: DEnosumab for the treatment of FIbrous Dysplasia/McCune-Albright Syndrome in adults (DeFiD): a randomized double-blind placebo-controlled trial | ||
| Medical condition: Fibrous Dysplasia/ McCune Albright Syndrome | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-004893-26 | Sponsor Protocol Number: D6992C00044 | Start Date*: 2007-05-03 |
| Sponsor Name:AstraZeneca AB | ||
| Full Title: An open-label, non-comparative trial to evaluate the safety, efficacy and pharmacokinetics of FASLODEX (fulvestrant) in girls with progressive precocious puberty associated with McCune-Albright Syn... | ||
| Medical condition: Progressive precocious puberty associated with McCune-Albright Syndrome | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) DE (Completed) IT (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.